Dr. Adam Schussheim
Claim this profileNovartis Investigative Site
Studies Cardiovascular Disease
Studies Coronary Artery Disease
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Adam Schussheim is currently running
Inclisiran + Statins
for Coronary Artery Disease
This trial is testing inclisiran, an injectable medication, to see if it can reduce plaque in heart arteries of patients with non-obstructive coronary artery disease who have not had previous heart events. Inclisiran works by lowering 'bad' cholesterol levels in the blood.
Recruiting1 award Phase 37 criteria
Lepodisiran
for Cardiovascular Disease
This trial is testing lepodisiran, a medication given as an injection under the skin. It targets people with high levels of lipoprotein(a) who have cardiovascular disease or are at risk of heart attack or stroke. The medication works by lowering lipoprotein(a) levels to reduce the risk of these cardiovascular events.
Recruiting1 award Phase 3
More about Adam Schussheim
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Adam Schussheim has experience with
- Pelacarsen (TQJ230)
- Inclisiran
- Placebo
- Lepodisiran
Breakdown of trials Adam Schussheim has run
Cardiovascular Disease
Coronary Artery Disease
Myocardial Ischemia
Coronary Heart Disease
Atherosclerotic Plaque
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam Schussheim specialize in?
Adam Schussheim focuses on Cardiovascular Disease and Coronary Artery Disease. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is Adam Schussheim currently recruiting for clinical trials?
Yes, Adam Schussheim is currently recruiting for 2 clinical trials in Bridgeport Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Adam Schussheim has studied deeply?
Yes, Adam Schussheim has studied treatments such as Pelacarsen (TQJ230), Inclisiran, Placebo.
What is the best way to schedule an appointment with Adam Schussheim?
Apply for one of the trials that Adam Schussheim is conducting.
What is the office address of Adam Schussheim?
The office of Adam Schussheim is located at: Novartis Investigative Site, Bridgeport, Connecticut 06610 United States. This is the address for their practice at the Novartis Investigative Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.